Matches in Wikidata for { <http://www.wikidata.org/entity/Q87403597> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q87403597 description "article scientifique publié en 2016" @default.
- Q87403597 description "artículu científicu espublizáu n'abril de 2016" @default.
- Q87403597 description "im April 2016 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87403597 description "scientific article published on 28 April 2016" @default.
- Q87403597 description "wetenschappelijk artikel" @default.
- Q87403597 description "наукова стаття, опублікована у квітні 2016" @default.
- Q87403597 name "Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials" @default.
- Q87403597 name "Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials" @default.
- Q87403597 type Item @default.
- Q87403597 label "Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials" @default.
- Q87403597 label "Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials" @default.
- Q87403597 prefLabel "Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials" @default.
- Q87403597 prefLabel "Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials" @default.
- Q87403597 P1433 Q87403597-AAFCF4E3-850F-4F14-A4FB-56D27A5975BB @default.
- Q87403597 P1476 Q87403597-39A42425-2E7F-48AA-A57A-C36619507D95 @default.
- Q87403597 P2093 Q87403597-7D652795-7109-48F8-85F2-BC903C889A93 @default.
- Q87403597 P2093 Q87403597-B759C5A2-650F-4BAD-80D9-501F553FB0CA @default.
- Q87403597 P2093 Q87403597-B899DB77-5739-473C-9CC1-015857EF92FC @default.
- Q87403597 P304 Q87403597-3C686984-C4D4-40CD-8D6C-6B2E139DE109 @default.
- Q87403597 P31 Q87403597-DE4F3AA4-D143-4AF6-9B42-C8F97C3900FA @default.
- Q87403597 P31 Q87403597-e231f7bc-3f3c-4fe1-ae5b-dd988a453606 @default.
- Q87403597 P356 Q87403597-63907010-9C77-4CE7-A32F-8246A2DD20F1 @default.
- Q87403597 P433 Q87403597-D746E6D1-0E8F-42F6-A53B-16C0DF10055C @default.
- Q87403597 P478 Q87403597-48CC14FC-28EC-41F5-AACA-48F242F66E05 @default.
- Q87403597 P577 Q87403597-4033D9E4-ED8B-4D4B-B2F3-A4FA1FF4C5B3 @default.
- Q87403597 P698 Q87403597-CA369A38-C5D4-4E6A-AC3E-B45ACB15D47A @default.
- Q87403597 P921 Q87403597-6CA1540D-0BB1-4FB2-A0C0-EE43A842B6C0 @default.
- Q87403597 P921 Q87403597-7B4CE880-964D-4BE1-827C-BB85459ACBAB @default.
- Q87403597 P356 DOM.12653 @default.
- Q87403597 P698 26936426 @default.
- Q87403597 P1433 Q5270109 @default.
- Q87403597 P1476 "Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials" @default.
- Q87403597 P2093 "C Campos" @default.
- Q87403597 P2093 "D D Ørsted" @default.
- Q87403597 P2093 "J A Davidson" @default.
- Q87403597 P304 "725-728" @default.
- Q87403597 P31 Q13442814 @default.
- Q87403597 P31 Q815382 @default.
- Q87403597 P356 "10.1111/DOM.12653" @default.
- Q87403597 P433 "7" @default.
- Q87403597 P478 "18" @default.
- Q87403597 P577 "2016-04-28T00:00:00Z" @default.
- Q87403597 P698 "26936426" @default.
- Q87403597 P921 Q3025883 @default.
- Q87403597 P921 Q42824827 @default.